Chapter 11 Pharmacologic modification of materials

Jeffrey A. Hubbell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

Original languageEnglish
Pages (from-to)121-127
Number of pages7
JournalCardiovascular Pathology
Volume2
Issue number3 SUPPL.
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Biocompatible Materials
Blood Platelets
Medicine
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pathology and Forensic Medicine

Cite this

Chapter 11 Pharmacologic modification of materials. / Hubbell, Jeffrey A.

In: Cardiovascular Pathology, Vol. 2, No. 3 SUPPL., 01.01.1993, p. 121-127.

Research output: Contribution to journalArticle

Hubbell, Jeffrey A. / Chapter 11 Pharmacologic modification of materials. In: Cardiovascular Pathology. 1993 ; Vol. 2, No. 3 SUPPL. pp. 121-127.
@article{b31209ca5fb4464fb86e4a0df048e5c1,
title = "Chapter 11 Pharmacologic modification of materials",
abstract = "Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.",
author = "Hubbell, {Jeffrey A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/1054-8807(93)90052-4",
language = "English",
volume = "2",
pages = "121--127",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Chapter 11 Pharmacologic modification of materials

AU - Hubbell, Jeffrey A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

AB - Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

UR - http://www.scopus.com/inward/record.url?scp=4043074637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043074637&partnerID=8YFLogxK

U2 - 10.1016/1054-8807(93)90052-4

DO - 10.1016/1054-8807(93)90052-4

M3 - Article

VL - 2

SP - 121

EP - 127

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

IS - 3 SUPPL.

ER -